Breast Cancer

NM (Lung Carcinoma) : Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study).
Maxwell F, de Margerie Mellon C, Bricout M, Cauderlier E, Chapelier M, Albiter M, Bourrier P, Espié M, de Kerviler E, de Bazelaire C. : Diagnostic strategy for the assessment of axillary lymph node status in breast cancer. Diagn Interv Imaging. 2015;96:1089-101.
L. Le Guennec, A. Bertrand, C. Laurent, H. Roze, J. Chastre, A Combes, CE. Luyt. : Diffuse cerebral microbleeds after extracorporeal membrane oxygenation support. Am J Respir Crit Care Med. 2015 Mar 1;191(5):594-6.
de Margerie-Mellon C, Kaci R, Laredo J-D, Bousson V. : Multiple small sclerotic bone lesions revealing invasive lobular breast carcinoma. Jt Bone Spine Rev Rhum. mar 2015;82(2):129-30.
Maxwell F, de Margerie Mellon C, Bricout M, Cauderlier E, Chapelier M, Albiter M, et al. : Diagnostic strategy for the assessment of axillary lymph node status in breast cancer. Diagn Interv Imaging. oct 2015;96(10):1089-101.
Bousquet G, Darrouzain F, de Bazelaire C, Ternant D, Barranger E, Winterman S, Madelaine-Chambin I, Thiebaut JB, Polivka M, Paintaud G, Culine S, Janin A. : Intrathecal Trastuzumab Halts Progression of CNS Metastases in Breast Cancer. J Clin Oncol. 2014 Dec 29. pii: JCO.2012.44.8894. [Epub ahead of print] PubMed PMID: 25547506.
Bousquet G, Feugeas JP, Ferreira I, Vercellino L, Jourdan N, Bertheau P, de Bazelaire C, Barranger E, Janin A. : Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma. Breast Cancer Res. 2014 Feb 11;16(1):401. doi: 10.1186/bcr3615. PubMed PMID: 24517529; PubMed Central PMCID: PMC3979114.
Thomassin-Naggara I, Perrot N, Dechoux S, Ribeiro C, Chopier J, de Bazelaire C. : Added value of one-view breast tomosynthesis combined with digital mammography according to reader experience. Eur J Radiol. 2015 Feb;84(2):235-41. doi:10.1016/j.ejrad.2014.10.022. Epub 2014 Nov 15. PubMed PMID: 25467641.
NM (Lung Cancer) : Assessment of Simplified Methods to Measure 18F-FLT Uptake Changes in EGFR-Mutated Non–Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor Treatment
NM (Lung Cancer) : [18F]FDG Positron Emission Tomography within Two Weeks of Starting Erlotinib Therapy Can Predict Response in Non-Small Cell Lung Cancer Patients
Bousquet G, Varna M, Ferreira I, Wang L, Mongiat-Artus P, Leboeuf C, de Bazelaire C, Faivre S, Bertheau P, Raymond E, Germain S, Janin A. : Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosis. Cancer Chemother Pharmacol. 2013 Dec;72(6):1183-93. doi: 10.1007/s00280-013-2300-0. Epub 2013 Sep 24. PubMed PMID: 24061866.
de Bazelaire C, Scémama A, Coffin A, Cohen S, Chapellier M, Sabatier F, Albiter M, de Kerviler E. : Perfusion studies in senology. Diagn Interv Imaging. 2013 Dec;94(12):1279-90. doi: 10.1016/j.diii.2013.06.011. Epub 2013 Jul 12. PubMed PMID: 23856648.
Lehmann-Che J, Hamy AS, Porcher R, Barritault M, Bouhidel F, Habuellelah H, Leman-Detours S, de Roquancourt A, Cahen-Doidy L, Bourstyn E, de Cremoux P, de Bazelaire C, Albiter M, Giacchetti S, Cuvier C, Janin A, Espié M, de Thé H, Bertheau P. : Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. Breast Cancer Res. 2013 May 11;15(3):R37. doi: 10.1186/bcr3421. PubMed PMID: 23663520; PubMed Central PMCID: PMC4053236.
Richard R, Thomassin I, Chapellier M, Scemama A, de Cremoux P, Varna M, Giacchetti S, Espié M, de Kerviler E, de Bazelaire C. : Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Eur Radiol. 2013 Sep;23(9):2420-31. doi: 10.1007/s00330-013-2850-x. Epub 2013 May 8. PubMed PMID: 23652844.
NM (Lung Cancer) : Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3′-Deoxy-3′-18F-Fluorothymidine PET Images in Lung Cancer
de Bazelaire C, Groheux D, Chapellier M, Sabatier F, Scémama A, Pluvinage A, Albiter M, de Kerviler E. : Breast inflammation: indications for MRI and PET-CT. Diagn Interv Imaging. 2012 Feb;93(2):104-15. doi: 10.1016/j.diii.2011.12.004. Epub 2012 Jan 21. PubMed PMID: 22305594.
Groheux D, Hindié E, Delord M, Giacchetti S, Hamy AS, de Bazelaire C, de Roquancourt A, Vercellino L, Toubert ME, Merlet P, Espié M. : Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer. J Natl Cancer Inst. 2012 Dec 19;104(24):1879-87. doi: 10.1093/jnci/djs451. Epub 2012 Dec 12. PubMed PMID: 23243198; PubMed Central PMCID: PMC3525816.
Hamy AS, Giacchetti S, Albiter M, de Bazelaire C, Cuvier C, Perret F, Bonfils S, Charvériat P, Hocini H, de Roquancourt A, Espie M. : BI-RADS categorisation of 2,708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit. Eur Radiol. 2012 Jan;22(1):9-17. doi: 10.1007/s00330-011-2201-8. Epub 2011 Jul 16. PubMed PMID: 21769528.
Thomassin-Naggara I, de Bazelaire C, Chopier J, Bazot M, Marsault C, Trop I. : Diffusion-weighted MR imaging of the breast: advantages and pitfalls. Eur J Radiol. 2013 Mar;82(3):435-43. doi: 10.1016/j.ejrad.2012.03.002. Epub 2012 May 31. Review. PubMed PMID: 22658868.
Humbert O, Berriolo-Riedinger A, Riedinger JM, Coudert B, Arnould L, Cochet A, et al. : Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes. Ann Oncol 2012.
de Bazelaire C, Calmon R, Thomassin I, Brunon C, Hamy AS, Fournier L, Balvay D, Espié M, Siauve N, Clément O, de Kerviler E, Cuénod CA. : Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study. BMC Cancer. 2011 Aug 19;11:361. doi: 10.1186/1471-2407-11-361. PubMed PMID: 21854572; PubMed Central PMCID: PMC3173447.
Lehmann-Che J, Amira-Bouhidel F, Turpin E, Antoine M, Soliman H, Legres L, Bocquet C, Bernoud R, Flandre E, Varna M, de Roquancourt A, Plassa LF, Giacchetti S, Espié M, de Bazelaire C, Cahen-Doidy L, Bourstyn E, Janin A, de Thé H, Bertheau P. : Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches. Br J Cancer. 2011 May 24;104(11):1739-46. doi: 10.1038/bjc.2011.135. Epub 2011 May 3. PubMed PMID: 21540864; PubMed Central PMCID: PMC3111154.
Cochet A, Quilichini G, Dygai-Cochet I, Touzery C, Toubeau M, Berriolo-Riedinger A, et al. : Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer. Breast Cancer Res Treat 2011;130:845-54.
Rousseau C, Devillers A, Campone M, Campion L, Ferrer L, Sagan C, Ricaud M, Bridji B, Kraeber-Bodéré F. : FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients. Eur J Nucl Med Mol Imaging. 2011 Feb 10.
P. Fosse, S. Girault, O. Capitain, I. Valo, F. Bouchet, L. Vervueren, F. Lacoeuille, O. Couturier, O. Morel. : Apport de la TEP-FDG dans le staging initial des cancers du sein localement avancés traités par chimiothérapie néo-adjuvante. Médecine Nucléaire 2011, 36(2) : 69-76
de Bazelaire C, Pluvinage A, Chapelier M, Hamy AS, Albiter M, Farges C, Bourrier P, Zagdanski AM, Espié M, de Kerviler E, Frija J. : Diffusion-weighted MR imaging of the breast. J Radiol. 2010 Mar;91(3 Pt 2):394-404; quiz 405-7. Review. French. PubMed PMID: 20508574.
Bertino C, Eliat Pa, Dedieu V, Lacroix J, Vincensini D, De Certaines J. Dynamic relaxometry of breast tumours : a multicenter study on 100 patients. 19 th annual meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) august 22-25 2005 : Cannes, France. MAGMA 2002 ; 15 supp11) : 258 (abstr527). : Dynamic relaxometry of breast tumours : a multicenter study on 100 patients. 19 th annual meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) august 22-25 2005 : Cannes, France. MAGMA 2002 ; 15 supp11) : 258 (abstr527).
Eliat Pa, Dedieu V, Bertino C, Boute V, Lacroix J, Constans Jm, De Korvin B, Vincent C, Bailly C, Joffre F, De Certaines J, Vincensini D. Magn Resib : Magnetic resonance imaging contrast-enchanced relaxometry of breast tumors : an MRI multicenter investigation concerning 100 patients. Imaging 2004 ; 22(4) : 475-81
Read More

Central Nervous System

Ben Bouallègue F, Mariano-Goulart D, Payoux P; : Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI. Alzheimer’s Disease Neuroimaging Initiative (ADNI). J Alzheimers Dis. 2018;62(1):399-408. doi: 10.3233/JAD-170833.
Ben Bouallègue F, Vauchot F, Mariano-Goulart D, Payoux P. : Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database. Brain Imaging Behav. 2018 Feb 9. doi: 10.1007/s11682-018-9833-0.
Ceccaldi M, Jonveaux T, Verger A, Krolak-Salmon P, Houzard C, Godefroy O, Shields T, Perrotin A, Gismondi R, Bullich S, Jovalekic A, Raffa N, Pasquier F, Semah F, Dubois B, Habert MO, Wallon D, Chastan M, Payoux P; NEUUS in AD study group, Stephens A, Guedj E. : Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study. Alzheimers Dement. 2018 Mar;14(3):293-305.
Desarnaud, S., Mellerio, C., Semah., F., Laurent, A., Landré, E., Devaux, B., Chiron,C., Lebon, V., Chassoux, F. : 18F-FDG PET in drug-resistant epilepsy due to focal cortical dysplasia type 2: additional value of electroclinical data and coregistration with MRI [published correction appears in Eur J Nucl Med Mol Imaging. 2018 Apr 28;:]. Eur J Nucl Med Mol Imaging. 2018;45(8):1449–1460. doi:10.1007/s00259-018-3994-3
Aziz AL, Giusiano B, Joubert S, Duprat L, Didic M, Gueriot C, Koric L, Boucraut J, Felician O, Ranjeva JP, Guedj E, Ceccaldi M. : Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer’s disease. Neurobiol Aging. 2017 Jun;54:22-30.
Van Der Gucht A, Aoun Sebaiti M*, Guedj E*, Aouizerate J, Yara S, Gherardi RK, Evangelista E, Chalaye J, Cottereau AS, Verger A, Bachoud-Levi AC, Abulizi M, Itti E, Authier FJ. : Brain FDG-PET metabolic abnormalities in patients with long-lasting macrophagic myofasciitis. J Nucl Med 2017;58:492-8. (IF: 5.849)
Vanhoutte, M., Semah, F., Rollin Sillaire, A., Jaillard, A., Petyt, G., Kuchcinski, G., Maureille, A., Delbeuck, X., Fahmi, R., Pasquier, F. & Lopes, R. (2017). : 18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer’s disease. Neurobiol Aging. 2017;59:184–196. doi:10.1016/j.neurobiolaging.2017.08.009
Chassoux, F., Artiges, E., Semah, F., Laurent, A., Landré, E., Turak, B., Gervais, P., Helal, B., Devaux, B. (2017) : 18F-FDG-PET patterns of surgical success and failure in mesial temporal lobe epilepsy. Neurology. 2017;88(11):1045–1053. doi:10.1212/WNL.0000000000003714
Payoux P, Salabert AS. : New PET markers for the diagnosis of dementia. Curr Opin Neurol. 2017 Sep 12. doi: 10.1097/WCO.0000000000000489.
Salabert AS, Mora-Ramirez E, Beaurain M, Alonso M, Fontan C, Tahar H, Boizeau ML, Tafani M, Bardiès M, Payoux P. : Evaluation of [18F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats. Nucl Med Biol. 2017 Dec 21;59:1-8.
Joubert S, Gour N, Guedj E, Didic M, Guériot C, Koric L, Ranjeva JP, Felician O, Guye M, Ceccaldi M. Cortex. : Early-onset and late-onset Alzheimer’s disease are associated with distinct patterns of memory impairment. 2016 Jan;74:217-32.
Koric L, Guedj E, Habert MO, Semah F, Branger P, Payoux P, Le Jeune F; : Molecular imaging in the diagnosis of Alzheimer’s disease and related disorders. CMMR study group. Rev Neurol (Paris). 2016 Dec;172(12):725-734.
Semah, F., Deberdt, M. & Ceccaldi, M. (2016). : Diagnostic de la maladie d’Alzheimer : apport de l’imagerie au florbétapir et autres radiopharmaceutiques de la plaque amyloïde. Médecine Nucléaire, 40, October 2016, 364-381. doi : 10.1016/j.mednuc.2016.08.001
Verclytte, S., Lopes, R., Lenfant, P., Rollin, A., Semah, F., Leclerc, X., Pasquier, F. & Delmaire, C. (2016). : Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer’s Disease. J Neuroimaging. 2016;26(2):207–212. doi:10.1111/jon.12264
Chassoux, F., Artiges, E., Semah., F., Desarnaud, S., Laurent, A., Landré, E., Gervais, P., Devaux, B., Helal,. B. (2016) : Determinants of brain metabolism changes in mesial temporal lobe epilepsy. Epilepsia. 2016;57(6):907–919. doi:10.1111/epi.13377
Collart Dutilleul, P., Ryvlin, P., Kahane, P., Vercueil, L., Semah, F., Biraben, A., Schwartz, J.C., De Seze, J., Hirsch, E. & Collongues, N. (2016). : Exploratory Phase II Trial to Evaluate the Safety and the Antiepileptic Effect of Pitolisant (BF2.649) in Refractory Partial Seizures, Given as Adjunctive Treatment During 3 Months. Clin Neuropharmacol. 2016;39(4):188–193.
Didic M, Felician O, Gour N, Bernard R, Pécheux C, Mundler O, Ceccaldi M, Guedj E. : Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks. Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1512-21.
Salabert AS, Fonta C , Fontan C, Adel D, Tafani M, Pestourie C, Belhadj-Tahar H, Alonso M, Payoux P. : Radiolabeling of [18F]-fluoroethylnormemantine and initial in vivo evaluation of this innovative PET tracer for imaging the PCP sites of NMDA receptors. Nucl Med Biol. 2015 Apr 7.
Tard, C., Demailly, F., Delval, A., Semah, F., Defebvre, L., Dujardin, K. & Moreau, C. (2015a). : Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson’s Disease. J Parkinsons Dis. 2015;5(3):569–574. doi:10.3233/JPD-150583
Semah, F., Thomas, P., Coulbaut, S. & Derambure, P. (2014). : Early add-on treatment vs alternative monotherapy in patients with partial epilepsy. Epileptic Disord. 2014;16(2):165–174. doi:10.1684/epd.2014.0650
Darcourt J, Schiazza A, Sapin N, Dufour M, Ouvrier MJ, Benisvy D, Fontana X, Koulibaly PM. : 18F-FDOPA PET for the diagnosis of parkinsonian syndromes. Q J Nucl Med Mol Imaging. 2014 Dec;58(4):355-65. Epub 2014 Nov 4. PubMed PMID: 25366711.
Petyt, G., Kreisler, A., Demailly, F., Olivier, A., Defebvre, L. & Semah, F. (2014). : Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism. J Neurol Sci. 2014;341(1-2):167–171. doi:10.1016/j.jns.2014.04.024
de Margerie-Mellon C, Turc G, Tisserand M, Naggara O, Calvet D, Legrand L, et al. Can : DWI-ASPECTS substitute for lesion volume in acute stroke? Stroke J Cereb Circ. dec 2013;44(12):3565-7.
Lenfant, P., Ravasi, L., Petyt, G., Lebouc, R., Henry, S., Pallardy, A., Genty, M., Foucher, C., Pasquier, F., Semah, F. & Lejeune, F. (2011). : Contribution of two techniques for automated analysis of (18)F FDG-PET scans to differentiate frontotemporal dementia from Alzheimer’s disease. Medecine Nucleaire-Imagerie Fonctionnelle Et Metabolique 2011, 35, 136-145.
Rolland Y, Vérin M, Payan CA, Duchesne S, Kraft E, Hauser TK, Jarosz J, Deasy N, Defevbre L, Delmaire C, Dormont D, Ludolph AC, Bensimon G, Leigh PN; NNIPPS Study Group. : A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):1025-32
Neurology : elaroussi, Boubakeur & Bracoud, Luc & Pachai, Chahin. (2011). Whole-brain and ventricular volume change measurement in multicenter clinical trials: A feasibility study of Jacobian Integration using ADNI data. Alzheimers & Dementia – ALZHEIMERS DEMENT. 7. 10.1016/j.jalz.2011.05.045.
Neurology : Belaroussi, Boubakeur & Bracoud, Luc & Pachai, Chahin. (2011). High-throughput and accurate segmentation of lateral ventricles using combined single atlas propagation and tissue classification: Application to ADNI and IBSR data. Biological Conservation – BIOL CONSERV. 7. 10.1016/j.jalz.2011.05.574.
Bordet, R., Dartigues, J.F., Dubois, B., Goehrs, J.M., Vernoux, L., Semah, F., Pasquier, F. & Bidaut-Mazel, C. (2010). : Biomarkers for the early stages of clinical development in Alzheimer’s disease. Therapie. 2010;65(4):285–283. doi:10.2515/therapie/2010040
Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, Någren K, Nobili F, Walker Z, Van Laere K. : EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):443-50.
Van Laere K, Varrone A, Booij J, Vander Borght T, Nobili F, Kapucu OL, Walker Z, Någren K, Tatsch K, Darcourt J. : EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):434-42.
Lefèvre G, Queyrel V, Maurage CA, Laurent C, Launay D, Lacour A, Charlanne H, Morell-Dubois S, Lambert M, Maillard H, Vermersch P, Hachulla E, Hatron PY. : Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy. J Neurol Sci. 2009 Dec 15;287(1-2):246-9.
Neurology : Belaroussi, Boubakeur & Bracoud, Luc & Bonnand, Fabrice & Vincent, Fabrice & Pachai, Chahin. (2008). Brain Atrophy Measurement In Multicenter Studies: Application Of Brain Boundary Shift Integral And Jacobian Integration.
Neurology : Dal-Pan A, Dudonné S, Bourassa P, Bourdoulous M, Tremblay C, Desjardins Y, Calon F. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer’s Disease. J Alzheimers Dis. 2017;55(1):115-135. doi: 10.3233/JAD-160281. PubMed PMID: 27662290.
Read More

Hematology

Chiche J, Reverso-Meinietti J, Mouchotte A, Rubio-Patiño C, Mhaidly R, Villa E, Bossowski JP, Proics E, Grima-Reyes M, Paquet A, Fragaki K, Marchetti S, Briere J, Ambrosetti D, Michiels JF, Molina TJ, Copie-Bergman C, Lehmann-Che J, Peyrottes I, Peyrade F, de Kerviler E, Taillan B, Garnier G, Verhoeyen E, Paquis-Flucklinger V, Shintu L, Delwail V, Delpech-Debiais C, Delarue R, Bosly A, Petrella T, Brisou G, Nadel B, Barbry P, Mounier N, Thieblemont C, Ricci JE. : GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors. Cell Metab. 2019 Feb 26. pii: S1550-4131
Bouard L, Bodet-Milin C, Bailly C, Guillaume T, Peterlin P, Garnier A, Bourgeois AL, Mahé B, Dubruille V, Blin N, Touzeau, C, Gastinne T, Lok A, Bonnet A, Béné MC, Gouill SL, Moreau P, Kraeber-Bodéré F, Chevallier P. : Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients. Biol Blood Marrow Transplant. 2018 Nov 24. pii: S1083-8791(18)30752-3. doi: 10.1016/j.bbmt.2018.11.019.
Bailly C, Carlier T,Jamet B, Eugene T, Touzeau C, Attal M, Hulin C, Facon T, Leleu X, Perrot A, Garderet L, Macro M, Caillot D, Moreau P, Kraeber-Bodéré F, Bodet-Milin. : Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study. C. Clin Cancer Res. 2018 Nov 1;24(21):5219-5224. doi: 10.1158/1078-0432.CCR-18-0741. Epub 2018 Aug 1
Bailly C, Gouard S, acombe M, Remaud-Le Saëc P, Chalopin B, Bourgeois M, Chouin N, Tripier R, Halime Z, Haddad F, Faivre-Chauvet A, Kraeber-Bodéré F, Chérel M, Bodet-Milin C. : Comparison of Immuno-PET of CD138 and PET imaging with 64CuCl2 and 18F-FDG in a preclinical syngeneic model of multiple myeloma. Oncotarget. 2018 Jan 3;9(10):9061-9072. doi: 10.18632/oncotarget.23886. eCollection 2018 Feb 6.
NM (Lymphoma) : Interobserver Agreement of Interim and End-of-Treatment 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials
NM (Lymphoma) : 18F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients
NM (Lymphoma) : Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma
Kraeber-Bodere F, Pallardy A, Maisonneuve H, Campion L, Moreau A, Soubeyran I, Le Gouill S, Tournilhac O, Daguindau E, Jardel H, Morineau N, Bouabdallah K, Gyan E, Moles MP, Gressin R, Berthou C, Sadot S, Moreau P, Deau B, Bodet-Milin C, Cazeau AL, Garin E, Salaun PY, Vuillez JP, Gouilleux-Gruart V, Barbet J, Wegener WA, Goldenberg DM, Lamy T, Soubeyran P. : Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial. Lancet Haematol. 2017 Jan;4(1):e35-e45.
Zwarthoed C, El-Galaly TC, Canepari M, Ouvrier MJ, Viotti J, Ettaiche M, Viviani S, Rigacci L, Trentin L, Rusconi C, Luminari S, Cantonetti M, Bolis S, Borra A, Darcourt J, Salvi F, Subocz E, Tajer J, Kulikowski W, Malkowski B, Zaucha JM, Gallamini A. : Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study. J Nucl Med. 2017 Aug;58(8):1249-1254.
Bailly C, Leforestier R, Jamet B, Carlier T, Bourgeois M, Guérard F, Touzeau C, Moreau P, Chérel M, Kraeber-Bodéré F, Bodet-Milin C.. : PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients Int J Mol Sci. 2017 Feb 18;18(2). (IF 3.26).
NM (Myeloma) : Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study
Bodet-Milin C, Kraeber-Bodéré F, Eugène T, Guérard F, Gaschet J, Bailly C, Mougin M, Bourgeois M, Faivre-Chauvet A, Chérel M, Chevallier P : Radioimmunotherapy for Treatment of Acute Leukemia.. Semin Nucl Med. 2016 Mar;46(2):135-46 (IF 3.34).
Battistella M, Sallé de Chou C, de Bazelaire C, Cayuela JM, de Kerviler E, Bagot M, Janin A. : Lymph node image-guided core-needle biopsy for cutaneous T-cell lymphoma staging. Br J Dermatol 2016 (sous presse).
Bernard S, Goldwirt L, Amorim S, Brice P, Brière J, de Kerviler E, Mourah S, Sauvageon H, Thieblemont C. Activity with ibrutinib in mantle cell lymphoma patients with central nervous system relapse. Blood. 2015 : Activity with ibrutinib in mantle cell lymphoma patients with central nervous system relapse. Blood. 2015
Varma G, Duhamel G, de Bazelaire C, Alsop DC. : Magnetization transfer from inhomogeneously broadened lines: A potential marker for myelin. Magn Reson Med. 2015 Feb;73(2):614-22. doi: 10.1002/mrm.25174. Epub 2014 Mar 6. PubMed PMID: 24604578.
Schlemmer F, Chevret S, Lorillon G, de Bazelaire C, Peffault de Latour R, Meignin V, Michallet M, Hermet E, Wyplosz B, Houdouin V, Marchand-Adam S, Socié G, Tazi A, Bergeron A. : Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation. Respir Med. 2014 Oct;108(10):1525-33. doi: 10.1016/j.rmed.2014.09.006. Epub 2014 Sep 16. PubMed PMID: 25260979.
Sasanelli M, Meignan M, Haioun C, Berriolo-Riedinger A, Casasnovas RO, Biggi A, Gallamini A, Siegel BA, Cashen AF, Véra P, Tilly H, Itti E. : Pre-therapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell 2014;41:2017-22. (IF: 5.537) lymphoma. Eur J Nucl Med Mol Imaging
Illidge TM, Mayes S, Pettengell R, Bates AT, Bayne M, Radford JA, Ryder WD, Le Gouill S, Jardin F, Tipping J, Zivanovic M, Kraeber-Bodere F, Bardies M, Bodet-Milin C, Malek E, Huglo D, Morschhauser F. : Fractionated 90Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria. J Clin Oncol. 2014 Jan 20;32(3):212-8.
Fleury I, Amorim S, Mounier N, Coiffier B, Dupuis J, Tilly H, Mazari MA, Filliatre L, Brière J, Brice P, de Kerviler E, Thieblemont C. : Management and prognosis of sixty-six B-cell non-Hodgkin lymphoma patients presenting with initial spinal cord compression: a French retrospective multicenter study. Leuk Lymphoma. 2014 ; 27:1-20.
Monjanel H, Deville L, Ram-Wolff C, Venon MD, Franchi P, Benet C, de Kerviler E, Malphettes M, Thieblemont C, Brice P. : Brentuximab vedotin in heavily treated Hodgkin and anaplastic large-cell lymphoma, a single centre study on 45 patients. Br J Haematol. 2014
D’Anastasi M, Notohamiprodjo M, Schmidt GP, Dürr HR, Reiser MF, Baur-Melnyk A. : Tumor Load in Patients with Multiple Myeloma: β2-Microglobulin Levels Versus Whole-Body MRI. AJR Am J Roentgenol. 2014 Oct;203(4):854-62.
NM (Lymphoma) : Prognostic Value and Clinical Impact of 18FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy
de Bazelaire C, Coffin A, Cohen-Zarade S, de Margerie-Mellon C, Scemama A, Sabatier F, Calmon R, de Kerviler E. : CT-guided biopsies in lung infections in patients with haematological malignancies. Diagn Interv Imaging. 2013 Feb;94(2):202-15. doi: 10.1016/j.diii.2012.12.008. Epub 2013 Jan 24. PubMed PMID: 23352879.
Gay J, Lemiale V, Meignin V, Bron C, de Bazelaire C, Schnell D, Canet E, Seguin A, Azoulay E. : Diagnostic contribution from pulmonary biopsies in hematology patients with acute respiratory failure from undetermined etiology. Minerva Anestesiol. 2013 Aug;79(8):853-60. Epub 2013 May 29. PubMed PMID: 23719652.
Itti E, Meignan M, Berriolo-Riedinger A, Biggi A, Cashen AF, Véra P, Tilly H, Siegel BA, Gallamini A, Casasnovas RO, Haioun C. : An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Nucl Med Mol Imaging 2013;9:1312-20. (IF: 5.537) Deauville criteria and ΔSUVmax. Eur J
NM (Lymphoma) : International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E, Vekhoff A, Cornet M, Isnard F, Brethon B, Lacroix C, Poirot JL, Bouges C, Derouin F, Tazi A, Ribaud P. : The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 2012 Feb 23;119(8):1831-7; quiz 1956. doi: 10.1182/blood-2011-04-351601. Epub 2011 Oct 18. PubMed PMID: 22010103.
de Kerviler E, Benet C, Brière J, de Bazelaire C. : Image-guided needle biopsy for diagnosis and molecular biology in lymphomas. Best Pract Res Clin Haematol. 2012 Mar;25(1):29-39. doi: 10.1016/j.beha.2012.01.006. Epub 2012 Feb 25. Review. PubMed PMID: 22409821.
NM (Lymphoma) : Analysis of the Deauville criteria for the assessment of interim PET in advanced stage Hodgkin lymphoma patients enrolled in the IVS study part I: Diagnostic accuracy and prognostic value
Romero M, Brière J, de Bazelaire C, Lebœuf C, Wang L, Ratajczak P, Sibon D, de Kerviler E, Thieblemont C, Janin A. : Aflibercept-mediated early angiogenic changes in aggressive B-cell lymphoma. Cancer Chemother Pharmacol. 2011 Nov;68(5):1135-43. doi: 10.1007/s00280-011-1589-9. Epub 2011 Mar 5. PubMed PMID: 21380563.
Sibon D, Ertault M, Al Nawakil C, de Bazelaire C, Franchi P, Brière J, de Kerviler E, Beranger N, Thieblemont C, Brice P. : Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients. Br J Haematol. 2011 Apr;153(2):191-8. doi: 10.1111/j.1365-2141.2011.08594.x. Epub 2011 Mar 8. PubMed PMID: 21385169.
Casasnovas RO, Meignan M, Berriolo-Riedinger A, Bardet S, Julian A, Thieblemont C, et al. : SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood 2011;118:37-43.
Leseur J, Devillers A, Williaume D, Le Prisé E, Fougerou C, Bouriel C, Levêque J, Monpetit E, Blanchot J, de Crevoisier R, Garin E. : 18 F-fluorodeoxyglucose PET/CT in cervix cancer: lymph node assessment and prognostic/predictive value of primary tumour analysis . Cancer Radiother. 2011 Dec;15(8):699-708.
Safar V, Dupuis J, Itti E, Jardin F, Fruchart C, Bardet S, Véra P, Copie-Bergman C, Rahmouni A, Tilly H, Meignan M, Haioun C. : Interim 18fluorodeoxyglucose PET scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab. J Clin Oncol 2011;30:184-90. (IF: 20.982)
Schnell D, Mayaux J, de Bazelaire C, Legoff J, Feuillet S, Scieux C, Andreu-Gallien J, Darmon M, Baruchel A, Schlemmer B, Azoulay E. : Risk factors for pneumonia in immunocompromised patients with influenza. Respir Med. 2010 Jul;104(7):1050-6. doi: 10.1016/j.rmed.2010.01.021. Epub 2010 Feb 24. PubMed PMID: 20181467.
de Bazelaire C, de Kerviler E. : From multislice CT to whole-body biomarker imaging in lymphoma patients. Eur Radiol. 2011 Mar;21(3):555-8. doi: 10.1007/s00330-010-2035-9. Epub 2010 Dec 21. PubMed PMID: 21174095.
Itti E, Juweid ME, Haioun C, Yeddes I, Hamza F, El Bez I, Lin C, Evangelista E, Dupuis J, Meignan M. : Improvement of early FDG-PET interpretation in diffuse large B-cell lymphoma : importance of the reference background. J Nucl Med 2010;51:1857-62. (IF: 5.849)
Moulin-Romsee G, Hindié E, Cuenca X, Brice P, Decaudin D, Bénamor M, Brière J, Anitei M, Filmont JE, Sibon D, de Kerviler E, Moretti JL. : 18F-FDG bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging 2010; 37 :1095-105.
Rolland D, Ribrag V, Haioun C, Ghesquieres H, Jardin F, Bouabdallah R, Franchi P, Briere J, de Kerviler E, Chassagne-Clement C, Raponi M, Houlgatte R, Jais JP, Thieblemont C. : Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma. Cancer Chemother Pharmacol. 2010 ;65:781-90
Chajari M, Lacroix J, Peny A.M., Chesnay E, Batalla A, Henry-Amar M, Delcambre C, Genot J.Y, Fruchart C, Bardet S. : Gallium 67 scintigraphy in lymphoma : is there a benefit of image fusion with computed tomograohy ? Eur J Nucl Med 2002 ; 29 (3) : 380-7.
Read More

Imaging

PET : Shaping for PET image analysis
Vallot D, Caselles O, Chaltiel L, Fernandez A, Gabiache E, Dierickx L, Zerdoud S, Bauriaud M, Courbon Frederic. : A clinical evaluation of the impact of Bayesian penalized likelihood Nuclear Medicine Communications 2017
de Margerie-Mellon C, de Bazelaire C, Montlahuc C, Lambert J, Martineau A, Coulon P et al. : Reducing radiation dose at chest CT: Comparison between model-based type iterative reconstruction, hybrid iterative reconstruction, and filtered-back projection. Acad Radiol. oct 2016;23(10):1246-54.
NM : Detection of bladder metabolic artifacts in (18)F-FDG PET imaging.
NM : Weighted quantification of 18 F-FDG tumor metabolism activity using fuzzy-thresholding to predict post-treatment tumor recurrence
NM : Hierarchies and shape-space for PET image segmentation
Didierlaurent D, Jaudet C, Ribes S, Batatia H, Dierickx LO, Zerdoud S, Brillouet S, Weyts K, Courbon F, Caselles O. : Comparison of an alternative and existing binning methods to reduce the acquisition duration of 4D PET/CT. Med Phys. 2014 Nov;41(11):112503. doi: 10.1118/1.4897612. 18.
NM : Discrete Mojette rotation on PET-CT images
Didierlaurent D, Ribes S, Batatia H, Jaudet C, Dierickx LO, : The retrospective binning method improves the consistency of phase binning in respiratory-gated PET/CT. Phys Med Biol. 2012 Dec 7;57(23):7829-41. doi: 10.1088/0031-9155/57/23/7829. PMID: 23135238
Cardio : Evaluation of 3D Discrete Angles Rotation Degradations for Myocardial Perfusion Imaging
Other : CEDIMS : Cloud ethical dicom image Mojette storage
Lacoeuille F, Hindré F, Denizot B, Bouchet F, Legras P, Couturier O, Askiénazy S, Benoit JP, Le Jeune JJ. : New starch-based radiotracer for lung perfusion scintigraphy. Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):146-55.
Other : The POSITOSCOPE: an easy-to-use communicating electronic lightbox
M Rubeaux, NV Joshi, MR Dweck, A Fletcher, M Motwani, LE Thomson, … : Motion correction of 18F-NaF PET for imaging coronary atherosclerotic plaques. Journal of Nuclear Medicine 57 (1), 54-59
PJ Slomka, M Rubeaux, L Le Meunier, D Dey, JL Lazewatsky, T Pan, … : Dual-gated motion-frozen cardiac PET with flurpiridaz F 18. Journal of Nuclear Medicine 56 (12), 1876-1881
J Betancur, M Rubeaux, TA Fuchs, Y Otaki, Y Arnson, L Slipczuk, … : Automatic valve plane localization in myocardial perfusion SPECT/CT by machine learning: anatomic and clinical validation. Journal of Nuclear Medicine 58 (6), 961-967
Y Brodov, M Fish, M Rubeaux, Y Otaki, H Gransar, M Lemley, J Gerlach, … : Quantitation of left ventricular ejection fraction reserve from early gated regadenoson stress Tc-99m high-efficiency SPECT. Journal of Nuclear Cardiology 23 (6), 1251-1261
M Rubeaux, MK Doris, A Alessio, PJ Slomka : Enhancing cardiac PET by motion correction techniques. Current cardiology reports 19 (2), 14
M Rubeaux, Y Xu, G Germano, DS Berman, PJ Slomka : Normal databases for the relative quantification of myocardial perfusion. Current cardiovascular imaging reports 9 (8), 22
M Rubeaux, N Joshi, MR Dweck, A Fletcher, M Motwani, LE Thomson, … : Demons versus level-set motion registration for coronary 18F-sodium fluoride PET. Medical Imaging 2016: Image Processing 9784, 97843Y
MK Doris, M Rubeaux, T Pawade, Y Otaki, Y Xie, D Li, BK Tamarappoo, … : Motion-Corrected Imaging of the Aortic Valve with 18F-NaF PET/CT and PET/MRI: A Feasibility Study. Journal of Nuclear Medicine 58 (11), 1811-1814
M Rubeaux, JC Nunes, L Albera, M Garreau : Medical image registration using Edgeworth-based approximation of Mutual Information. Irbm 35 (3), 139-148
MK Doris, Y Otaki, SK Krishnan, J Kwiecinski, M Rubeaux, A Alessio, … : Optimization of reconstruction and quantification of motion-corrected coronary PET-CT. Journal of Nuclear Cardiology, 1-11
M Rubeaux : “Approximation de l’Information Mutuelle basée sur le développement d’Edgeworth: application au recalage d’images médicales. “
M Rubeaux, N Joshi, M Dweck, A Fletcher, M Motwani, G Germano, … : “Motion-frozen” 18F-sodium fluoride PET for imaging coronary atherosclerotic plaques. Journal of Nuclear Medicine 56 (supplement 3), 79-79
J Betancur, M Rubeaux, T Fuchs, L Slipczuk, G Germano, D Dey, … : Automatic valve plane localization in myocardial perfusion SPECT images using machine learning. Journal of Nuclear Medicine 57 (supplement 2), 288-288
G Santini, N Moreau, M Rubeaux : KiTS19 challenge Kidney tumor segmentation using an ensembling multi-stage deep learning approach. A contribution to the KiTS19 challenge – arXiv preprint arXiv:1909.00735, 2019 – arxiv.org https://arxiv.org/abs/1909.00735
Read More

Liver Cancer

Garin E, Rolland Y, Edeline J. : 90Y-Loaded Microsphere SIRT of HCC Patients With Portal Vein Thrombosis: High Clinical Impact of 99mTc-MAA SPECT/CT-Based Dosimetry. Semin Nucl Med. 2019;49(3):218–226. doi:10.1053/j.semnuclmed.2019.01.006
Edeline J, Touchefeu Y, Guiu B, et al. : Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial [published online ahead of print, 2019 Oct 31]. JAMA Oncol. 2019;e193702. doi:10.1001/jamaoncol.2019.3702
Bourien H, Palard X, Rolland Y, et al. : Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience. Eur J Nucl Med Mol Imaging. 2019;46(3):669–676. doi:10.1007/s00259-018-4199-5
Delaunay K, Edeline J, Rolland Y, et al. : Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization. Eur J Nucl Med Mol Imaging. 2019;46(7):1506–1517. doi:10.1007/s00259-019-04277-9
Bourien H, Palard X, Rolland Y, et al. : Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience. Eur J Nucl Med Mol Imaging. 2019;46(3):669–676. doi:10.1007/s00259-018-4199-5
Winter KS, Hofmann FO, Thierfelder KM, Holch JW, Hesse N, Baumann AB, Modest DP, Stintzing S, Heinemann V, Ricke J, Sommer WH, D’Anastasi M. : Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases. Eur Radiol. 2018 May 7.
Garin E, Rolland Y, Campillo-Gimenez B, Edeline J. : Negative phase 3 study of 90Y microspheres versus sorafenib in HCC. Lancet Oncol. 2018;19(2):e70. doi:10.1016/S1470-2045(18)30024-X
Palard X, Edeline J, Rolland Y, et al. : Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2018;45(3):392–401. doi:10.1007/s00259-017-3845-7
Simoncini C, Jurczuk K, Reska D, et al. : Towards a patient-specific hepatic arterial modeling for microspheres distribution optimization in SIRT protocol. Med Biol Eng Comput. 2018;56(3):515–529. doi:10.1007/s11517-017-1703-1
Manceau V, Palard X, Rolland Y, et al. : A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy. Eur J Nucl Med Mol Imaging. 2018;45(10):1731–1741. doi:10.1007/s00259-018-3990-7
Palard X, Edeline J, Rolland Y, et al. : Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2018;45(3):392–401. doi:10.1007/s00259-017-3845-7
Vilgrain V, Pereira H, Assenat E, et al. : Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lancet Oncol. 2017;18(12):1624–1636. doi:10.1016/S1470-2045(17)30683-6
Garin E, Rolland Y, Pracht M, et al. : High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization. Liver Int. 2017;37(1):101–110. doi:10.1111/liv.13220
Garin E, Rolland Y, Laffont S, Edeline J. : Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres. Eur J Nucl Med Mol Imaging. 2016;43(3):559–575. doi:10.1007/s00259-015-3157-8
Garin E, Edeline J, Rolland Y. : High Impact of Preferential Flow on 99mTc-MAA and 90Y-Loaded Microsphere Uptake Correlation. J Nucl Med. 2016;57(11):1829–1830. doi:10.2967/jnumed.116.175943
Garin E, Rolland Y, Laffont S, Edeline J. : Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres. Eur J Nucl Med Mol Imaging. 2016;43(3):559–575. doi:10.1007/s00259-015-3157-8
Beuzit L, Edeline J, Brun V, et al. : Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT). Eur J Radiol. 2016;85(8):1445–1452. doi:10.1016/j.ejrad.2016.05.020
Edeline J, Crouzet L, Campillo-Gimenez B, et al. : Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis. Eur J Nucl Med Mol Imaging. 2016;43(4):635–643. doi:10.1007/s00259-015-3210-7
Edeline J, Du FL, Rayar M, et al. : Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic Cholangiocarcinoma. Clin Nucl Med. 2015;40(11):851–855. doi:10.1097/RLU.0000000000000904
Carlier T, Eugène T, Bodet-Milin C, Garin E, Ansquer C, Rousseau C, Ferrer L, Barbet J, Schoenahl F, Kraeber-Bodéré F. : Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT. EJNMMI Res. 2013 Feb 17;3(1):11.
Fosse P, Girault S, Hoareau J, Testard A, Couturier O, Morel O. : Unusual uptake of 18FDG by a hepatic adenoma. Clin Nucl Med. 2013 Feb;38(2):135-6.
Boudjema K, Sulpice L, Garnier S, Bretagne JF, Gandon Y, Rohou T. : A Simple System to Predict Perihilar Cholangiocarcinoma Resectability. J Gastrointest Surg. 2013 May 9
Masserot-Lureau C, Adoui N, Degos F, de Bazelaire C, Soulier J, Chevret S, Socié G, Leblanc T. : Incidence of liver abnormalities in Fanconi anemia patients. Am J Hematol. 2012 May;87(5):547-9. doi: 10.1002/ajh.23153. Epub 2012 Apr 10. PubMed PMID: 22488129.
Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, Porée P, Clément B, Raoul JL, Boucher E. : Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med. 2012 Feb;53(2):255-63.
Edeline J, Boucher E, Rolland Y, Vauléon E, Pracht M, Perrin C, Le Roux C, Raoul JL : Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma. Cancer. 2012 Jan 1;118(1):147-56.
Lenoir L, Edeline J, Rolland Y, Pracht M, Raoul JL, Ardisson V, Bourguet P, Clément B, Boucher E, Garin E. : Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization. Eur J Nucl Med Mol Imaging. 2012 Jan 12.
Garin E, Lenoir L, Rolland Y, Laffont S, Pracht M, Mesbah H, Porée P, Ardisson V, Bourguet P, Clement B, Boucher E. : Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-labeled microspheres. Nucl Med Commun. 2011 Dec;32(12):1245-55.
Garin E, Rolland Y, Lenoir L, Pracht M, Mesbah H, Porée P, Laffont S, Clement B, Raoul JL, Boucher E. : Utility of Quantitative Tc-MAA SPECT/CT for yttrium-Labelled Microsphere Treatment Planning: Calculating Vascularized Hepatic Volume and Dosimetric Approach. Int J Mol Imaging. 2011;2011:398051.
Le Roux PY, Bouchet F, Querellou S, Vervueren L, Lacoeuille F, Turzo A, Salaun PY, Couturier OF. : American consensus recommendations for gastric scintigraphy : curve fitting with only a few points remains an easy and accurate method to obtain reliable and reproducible gastric emptying estimates. Nucl Med Commun. 2011 Jan;32(1):30-6
Raoul JL, Edeline J, Pracht M, Boucher E, Rolland Y, Garin E. : Radioembolisation for hepatocellular carcinoma. Cancer Radiother 2011, 15: 64-8.
Garin E, Rolland Y, Boucher E, Ardisson V, Laffont S, Boudjema K, Bourguet P, Raoul JL. : First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation. Eur J Nucl Med Mol Imaging 2010 ;37:453-61.
Le Dortz L, De Guibert S, Bayat S, Devillers A, Houot R, Rolland Y, Cuggia M, Le Jeune F, Bahri H, Barge ML, Lamy T, Garin E. : Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2307-14. Epub 2010 Aug 18
Raoul JL, Boucher E, Rolland Y, Garin E. : Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides. Nat Rev Gastroenterol Hepatol 2010 ; 7:41-9.
Read More

Lung Cancer

de Margerie-Mellon C, VanderLaan PA, Bankier AA. : CT Manifestations of Tumor Spread through Air Spaces in Lung Adenocarcinoma: Different Pathways toward Common Perspectives. Radiology. 2019 Jan; 290(1):271-272
de Margerie-Mellon C, Gill RR, Monteiro Filho AC, et al. : Growth Assessment of Pulmonary Adenocarcinomas Manifesting as Subsolid Nodules on CT: Comparison of Diameter-Based and Volume Measurements [published online ahead of print, 2019 Nov 13]. Acad Radiol. 2019;S1076-6332(19)30491-X. doi:10.1016/j.acra.2019.09.028
Bergeron A, Chevret S, Peffault de Latour R, Chagnon K, de Margerie-Mellon C, Rivière F, Robin M, Mani J, Lorillon G, Socié G, Tazi A. : Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation. Eur Respir J. 2018 May 3;51(5) pii: 1702617.
de Margerie-Mellon C, Onken A, VanderLaan PA, Bankier AA. : CT manifestations of STAS (Tumor Spread through Airspaces) in Pulmonary Adenocarcinomas presenting as Subsolid Nodules. J Thorac Imaging. 2018 Nov; 33(6):402-408.
de Margerie-Mellon C, Heidinger BH, Bankier AA. : 2D or 3D measurements of pulmonary nodules: preliminary answers and more open questions. Journal of Thoracic Disease. 2018 Feb; 10(2):547-549.
Lorillon G, Jouenne F, Baroudjian B, de Margerie-Mellon C, Vercellino L, Meignin V, Lebbe C, Vassallo R, Mourah S, Tazi A. : Response to Trametinib of a Pulmonary Langerhans Cell Histiocytosis Harboring a MAP2K1 Deletion. Am J Respir Crit Care Med. 2018 Sep 1;198(5):675-678.
Cornetto MA, de Margerie-Mellon C, Ribaud P, Bergeron A. : Reply to “Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation”. Biol Blood Marrow Transplant. oct 2016;22(10):1910.
Cornetto MA, Chevret S, Abbes S, de Margerie-Mellon C, Hussenet C, de Fontbrune FS et al. : Early lung CT scan after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. aug 2016;22(8):1511-6.
de Margerie-Mellon C, de Bazelaire C, de Kerviler E. : Image-guided biopsy in primary lung cancer: why, when, how? Diagn Interv Imaging. oct 2016;97(10):965-72
Groheux D, Quere G, Blanc E, Lemarignier C, Vercellino L, de Margerie-Mellon C et al. : FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review. Diagn Interv Imaging. oct 2016;97(10):1003-17.
Lorillon G, Mourah S, Vercellino L, de Margerie-Mellon C, Pagès C, Goldwirt L et al. : Sustained response to salvage therapy for dabrafenib-resistant metastatic Langerhans cell sarcoma. Ann Oncol. dec 2016;27(12):2305-2307
Obert J, Vercellino L, Van Der Gucht A, de Margerie-Mellon C, Bugnet E, Chevret S et al. : 18F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosis. Eur J Nucl Med Mol Imaging. 20 sept 2016.
Mourah S, Lorillon G, Meignin V, Vercellino L, de Margerie-Mellon C, Pages C, et al. : Dramatic transient improvement of metastatic BRAFV600E-mutated Langerhans cell sarcoma under treatment with dabrafenib. Blood. dec 2015;126(24):2649-52.
Mammar Hachemi, Olivier Couturier, Laurent Vervueren, Pacôme Fosse, Franck Lacœuille, Thierry Urban, José Hureaux. : [18F]FDG Positron Emission Tomography within two weeks of starting erlotinib therapy can predict response in non-small cell lung cancer patients. Clinical Lung Cancer. PLoS One. 2014 Feb 5;9(2):e87629. doi: 10.1371/journal.pone.0087629. eCollection 2014.
E.L. Cohen-Jonathan Moyal, C. Massabeau, T Filleron, A Modesto, J Bachaud, I Rouquette, L Dierickx, R Aziza, L Bigay-Gamé, G Plat, M Mounier, CA Gomez-Roca, J Delord, J Mazieres : Continuous infusion of cilengitide with radiochemotherapy in stage III NSCLC: a phase I study SP 0598 ESMO 2014
Read More

Solid Tumors

Salaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, Coriat R, Hindie E, Taieb D, Tabarin A, Girard A, Grellier JF, Brenot-Rossi I, Groheux D, Rousseau C, Deandreis D, Alberini JL, Bodet-Milin C, Itti E, Casasnovas O, Kraeber-Bodere F, Moreau P, Philip A, Balleyguier C, Lucian A, Cachin F. : Good clinical practice recommendations for the use of PET/CT in oncology. Eur J Nucl Med Mol Imaging 47, 28–50 (2020). https://doi.org/10.1007/s00259-019-04553-8
Nougaret S, Tibermacine H, Tardieu M, Sala E. : Radiomics: an Introductory Guide to What It May Foretell. Curr Oncol Rep. 2019;21(8):70. Published 2019 Jun 25. doi:10.1007/s11912-019-0815-1
Salaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, Coriat R, Hindie E, Taieb D, Tabarin A, Girard A, Grellier JF, Brenot-Rossi I, Groheux D, Rousseau C, Deandreis D, Alberini JL, Bodet-Milin C, Itti E, Casasnovas O, Kraeber-Bodere F, Moreau P, Philip A, Balleyguier C, Lucian A, Cachin F. : Update of the recommendations of good clinical practice for the use of PET in oncology. Bull Cancer. 2019 Mar;106(3):262-274. doi: 10.1016/j.bulcan.2019.01.002. Epub 2019 Jan 23
” S Nougaret 1 , M Tardieu 2 , H A Vargas 3 , C Reinhold 4 , S Vande Perre 5 , N Bonanno 6 , E Sala 7 , I Thomassin-Naggara 5″ : Ovarian cancer: An update on imaging in the era of radiomics. Diagn Interv Imaging 100 (10), 647-655 Oct 2019 DOI: 10.1016/j.diii.2018.11.007
Himoto Y, Cybulska P, Shitano F, et al. : Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?. Gynecol Oncol. 2019;155(2):192–200. doi:10.1016/j.ygyno.2019.08.011
Meier A, Veeraraghavan H, Nougaret S, et al. : Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancer. Abdom Radiol (NY). 2019;44(6):2040–2047. doi:10.1007/s00261-018-1840-5
Nougaret S, Horta M, Sala E, et al. : Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology. Eur Radiol. 2019;29(2):792–805. doi:10.1007/s00330-018-5515-y
Nougaret S, Nikolovski I, Paroder V, et al. : MRI of Tumors and Tumor Mimics in the Female Pelvis: Anatomic Pelvic Space-based Approach. Radiographics. 2019;39(4):1205–1229. doi:10.1148/rg.2019180173
Nougaret S, Jhaveri K, Kassam Z, Lall C, Kim DH. : Rectal cancer MR staging: pearls and pitfalls at baseline examination. Abdom Radiol (NY). 2019;44(11):3536–3548. doi:10.1007/s00261-019-02024-0
Ganeshan D, Nougaret S, Korngold E, Rauch GM, Moreno CC. : Locally recurrent rectal cancer: what the radiologist should know. Abdom Radiol (NY). 2019;44(11):3709–3725. doi:10.1007/s00261-019-02003-5
Hope TA, Gollub MJ, Arya S, et al. : Rectal cancer lexicon: consensus statement from the society of abdominal radiology rectal & anal cancer disease-focused panel. Abdom Radiol (NY). 2019;44(11):3508–3517. doi:10.1007/s00261-019-02170-5
Nougaret S, Castan F, de Forges H, et al. : Early MRI predictors of disease-free survival in locally advanced rectal cancer from the GRECCAR 4 trial. Br J Surg. 2019;106(11):1530–1541. doi:10.1002/bjs.11233
Sun S, Bonaffini PA, Nougaret S, et al. : How to differentiate uterine leiomyosarcoma from leiomyoma with imaging. Diagn Interv Imaging. 2019;100(10):619–634. doi:10.1016/j.diii.2019.07.007
NM (aknowledgment) : Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics
Morin S, Grateau A, Reuter D, de Kerviler E, de Margerie-Mellon C, de Bazelaire C, Zafrani L, Schlemmer B, Azoulay E, Canet E. : Management of superior vena cava syndrome in critically ill cancer patients. Support Care Cancer. 2018 Feb;26(2):521-528.
Pierre Pascal, Laurent Dercle, Kathleen Weyts, Slimane Zerdoud, Lawrence O. Dierickx, Nicolas Meyer, Frederic Courbon : Complete Metabolic Response of Advanced Melanoma to Vemurafenib Assessed with FDG-PET-CT at 85 Hours. Clin Nucl Med. 2018;43(5):333–334. doi:10.1097/RLU.0000000000002032
Nougaret S, Lakhman Y, Molinari N, et al. : CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. AJR Am J Roentgenol 2018; 210:918-926

Nougaret S, Lakhman Y, Molinari N, et al. : CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas. AJR Am J Roentgenol. 2018;210(4):918–926. doi:10.2214/AJR.17.18254

Kubik-Huch RA, Weston M, Nougaret S, et al. : European Society of Urogenital Radiology (ESUR) Guidelines:MR Imaging of Leiomyomas. Eur Radiol 2018; 28:3125-3137
Nougaret S, Horta M, Sala E, et al. : Endometrial Cancer MRI staging: Updated Guidelines of the European Society of Urogenital Radiology. Eur Radiol 2018;
Corines MJ, Nougaret S, Weiser MR, Khan M, Gollub MJ. : Gadolinium-Based Contrast Agent During Pelvic MRI: Contribution to Patient Management in Rectal Cancer. Dis Colon Rectum 2018; 61:193-201
Escal L, Nougaret S, Guiu B, et al. : MRI-based score to predict surgical difficulty in patients with rectal cancer. Br J Surg 2018; 105:140-146
Fraisse G, Colleter L, Peyronnet B, Khene ZE, Mandoorah Q, Soorojebally Y, Bourgi A, De La Taille A, Roupret M, De Kerviler E, Desgrandchamps F, Bensalah K, Masson-Lecomte A. : Peri-operative and local control outcome of robot-assisted partial nephrectomy vs percutaneous cryoablation for renal masses. Comparison after matching on radiological stage and renal score. BJU Int 2018 (in press).
NM (Prostate) : Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study
NM (Neuroblastoma) : Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO
Nougaret S, Lakhman Y, Vargas HA, et al. : From Staging to Prognostication: Achievements and Challenges of MR Imaging in the Assessment of Endometrial Cancer. Magn Reson Imaging Clin N Am 2017; 25:611-633
Bourgeois M, Bailly C, Frindel M, Guerard F, Chérel M, Faivre-Chauvet A, Kraeber-Bodéré F, Bodet-Milin C. : Radioimmunoconjugates for treating cancer: recent advances and current opportunities. Expert Opin Biol Ther. 2017 Jul;17(7):813-819
Rouchy RC, Moreau-Gaudry A, Chipon E, Aubry S, Pazart L, Lapuyade B, Durand M, Hajjam M, Pottier S, Renard B, Logier R, Orry X, Cherifi A, Quehen E, Kervio G, Favelle O, Patat F, De Kerviler E, Hughes C, Medici M, Ghelfi J, Mounier A, Bricault I. : Evaluation of the clinical benefit of an electromagnetic navigation system for CT-guided interventional radiology procedures in the thoraco-abdominal region compared with conventional CT guidance (CTNAV II): study protocol for a randomised controlled trial. Trials. 2017;18:306.
Weill C, Suissa L, Darcourt J, Mahagne MH. : The Pathophysiology of Watershed Infarction: A Three-Dimensional Time-of-Flight Magnetic Resonance Angiography Study. J Stroke Cerebrovasc Dis. 2017 Sep;26(9):1966-1973.
Nougaret S, Lakhman Y, Gonen M, et al. : High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes. Radiology 2017; 285:472-481
Dierickx LO, Dercle L, Chaltiel L, Caselles O, Brillouet S, Zerdoud S, Courbon F.Q : Evaluation of 2 diuretic 18Fluorine-Fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intra-pelvic cancer. J Nucl Med Mol Imaging. 2017 Mar 29. doi: 10.23736/S1824-4785.17.02912-0. [Epub ahead of print]PMID:28358186
Commandeur F, Simon A, Mathieu R, et al. : MRI to CT Prostate Registration for Improved Targeting in Cancer External Beam Radiotherapy. IEEE J Biomed Health Inform. 2017;21(4):1015–1026. doi:10.1109/JBHI.2016.2581881
Gnep K, Fargeas A, Gutiérrez-Carvajal RE, et al. : Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. J Magn Reson Imaging. 2017;45(1):103–117. doi:10.1002/jmri.25335
Commandeur F, Simon A, Mathieu R, et al. : MRI to CT Prostate Registration for Improved Targeting in Cancer External Beam Radiotherapy. IEEE J Biomed Health Inform. 2017;21(4):1015–1026. doi:10.1109/JBHI.2016.2581881
Nougaret S, Robertson N, Golia Pernicka J, et al. : The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer. Abdom Radiol (NY) 2017; 42:1968-1974
Prud’homme C, de Margerie-Mellon C, de Bazelaire C, de Kerviler E. : Coaxial versus Noncoaxial Techniques in Percutaneous Core Needle Biopsy of Renal Parenchyma. Cardiovasc Intervent Radiol. 2017 May;40(5):799-800.
Lakhman Y, D’Anastasi M, Micco M, et al. : Second-Opinion Interpretations of Gynecologic Oncologic MRI Examinations by Sub-Specialized Radiologists Influence Patient Care. Eur Radiol 2016; 26:2089-2098
Nougaret S, Reinhold C, Lakhman Y, Guiu B, Sala E. : The Wheel of the Mesentery: Imaging Spectrum of Primary and Secondary Mesenteric Neoplasms–How Can Radiologists Help Plan Treatment?: Resident and Fellow Education Feature. Radiographics. 2016;36(2):412–413. doi:10.1148/rg.2016150186
Cabannes-Hamy A, Lemal R, Goldwirt L, Poulain S, Amorim S, Pérignon R, Berger J, Brice P, De Kerviler E, Bay JO, Sauvageon H, Beldjord K, Mourah S, Tournilhac O, Thieblemont C. : Efficacy of ibrutinib in the treatment of Bing-Neel syndrome. Am J Hematol. 2016 Mar;91(3):E17-9.
Kraeber-Bodere F, Bailly C, Chérel M, Chatal JF. : ImmunoPET to help stratify patients for targeted therapies and to improve drug development. Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2166-2168
Rousseau C, Rousseau T, Mathieu C, Lacoste J, Potiron E, Aillet G, Nevoux P, Le Coguic G, Campion L, Kraeber-Bodéré F. : Laparoscopic sentinel lymph node dissection in prostate cancer patients: the additional value depends on preoperative data. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1849-56.
Nougaret S, Rouanet P. : Restaging rectal cancer after neoadjuvant treatment with multiparametric MRI: A landscape of new opportunities. Diagn Interv Imaging 2016; 97:839-841
Bodet-Milin C, Faivre-Chauvet A, Carlier T, Rauscher A, Bourgeois M, Cerato E, Rohmer V, Couturier O, Drui D, Goldenberg DM, Sharkey RM, Barbet J, Kraeber-Bodere F. Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial. J Nucl Med. 2016 Oct;57(10):1505-1511. : Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial. J Nucl Med. 2016 Oct;57(10):1505-1511.
Bodet-Milin C, Faivre-Chauvet A, Carlier T, Rauscher A, Bourgeois M, Cerato E, Rohmer V, Couturier O, Drui D, Goldenberg DM, Sharkey RM, Barbet J, Kraeber-Bodere F. : Immuno-PET using anti-CEA bispecific antibody and 68Ga-labeled peptide in metastatic medullary thyroid carcinoma: clinical optimization of the pretargeting parameters in a First-in Human trial. J Nucl Med. 2016 2016 :57(10):1505-1511. (IF5,85).
NM (Head & Neck Cancer) : Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy
NM (aknowledgment) : For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time
NM (Neurofibromatosis) : Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1
NM (cervical cancer) : Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer
Nougaret S, Reinhold C, Alsharif SS, et al. : Endometrial Cancer: Combined MR Volumetry and Diffusionweighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade. Radiology 2015; 276:797-808
Lakhman Y*, D’Anastasi M*, Miccò M, Scelzo C, Vargas HA, Nougaret S, Sosa RE, Chi DS, Abu-Rustum NR, Hricak H, Sala E. : Second-Opinion Interpretations of Gynecologic Oncologic MRI Examinations by Sub- Specialized Radiologists Influence Patient Care. Eur Radiol. 2015 Oct 22.
de Margerie-Mellon C, de Bazelaire C, Amorim S, Brice P, Tazi A, Brière J, et al. : Diagnostic Yield and Safety of Computed Tomography-guided Mediastinal Core Needle Biopsies. J Thorac Imaging. sept 2015;30(5):319-27.
Cercueil JP, Petit JM, Nougaret S, et al. : Intravoxel incoherent motion diffusion-weighted imaging in the liver: comparison of mono-, bi- and tri-exponential modelling at 3.0-T. Eur Radiol 2015; 25:1541-1550
Mannelli L, Nougaret S, Vargas HA, Do RK. : Advances in diffusion-weighted imaging. Radiol Clin North Am 2015; 53:569-581
Bohelay G, Battistella M, Pagès C, de Margerie-Mellon C, Basset-Seguin N, Viguier M, Kerob D, Madjlessi N, Baccard M, Archimbaud A, Comte C, Mourah S, Porcher R, Bagot M, Janin A, De Kerviler E, Lebbé C. : Ultrasound-guided core needle biopsy of superficial lymph nodes: an alternative to fine-needle aspiration cytology for the diagnosis of lymph node metastasis in cutaneous melanoma. Melanoma Res. 2015 
Aziz AL, Courbon F, Dierickx LO, Pascal P, Zerdoud S. : Oncocytic Adenoma of Thyroid Incidentally Detected by 18F-Fluorocholine PET/CT. J Nucl Med Technol. 2015 Jun;43(2):133-4. doi: 10.2967/jnmt.114.145433.
Lakhman Y, Nougaret S, Micco M, et al. : Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies. Radiographics 2015; 35:1295-1313
Anne-Laure Aziz, Lawrence Dierickx, Frederic Courbon, David Taieb and Slimane Zerdoud : 18F-18-L-Dihydroxyphenylalanine (18F-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of 18F-DOPA’ Clinical case reports 2015; 3(2):81-83 doi 10.1002/ccr.159
Quero L, Vercellino L, de Kerviler E, Mongiat-Artus P, Culine S, Merlet P, Ravery V, Meria P, Desgrandchamps F, Hennequin C. : 18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer. Clin Nucl Med. 2015 (in press)
Fujii S, Nougaret S, Escal L, et al. : MR imaging of locally advanced low rectal cancer: Relationships between imaging findings and the pathological tumor regression grade. J Magn Reson Imaging 2015; 42:421-426
de Kerviler E, de Margerie-Mellon C, Coffin A, Legrand G, Resche-Rigon M, Ploussard G, et al. : The feasibility of percutaneous renal cryoablation under local anaesthesia. Cardiovasc Intervent Radiol. jun 2015;38(3):672-7.
Anne-Laure Aziz, Lawrence Dierickx, Frederic Courbon,, David Taieb and Slimane Zerdoud ‘: 18F-18-L-Dihydroxyphenylalanine (18F-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of 18F-DOPA’ Clinical case reports 2015; 3(2):81-83 doi 10.1002/ccr.159 19.
Aziz AL, Courbon F, Dierickx LO, Pascal P, Zerdoud S : Oncocytic Adenoma of Thyroid Incidentally Detected by 18F-Fluorocholine PET/CT.. J Nucl Med Technol. 2015 Jun;43(2):133-4. doi: 10.2967/jnmt.114.145433. 20.
General (aknowledgment) : Apparent Diffusion Coefficient Is Highly Reproducible on Preclinical Imaging Systems: Evidence From a Seven-Center Multivendor Study
CT (Tumor volumetry) : Inter-Method Performance Study of Tumor Volumetry Assessment on Computed Tomography Test-Retest Data
de Bazelaire C, Coffin A, Cohen S, Scemama A, de Kerviler E. : Biopsies in oncology. Diagn Interv Imaging. 2014 Jul-Aug;95(7-8):647-57. doi: 10.1016/j.diii.2014.04.016. Epub 2014 Jul 17. PubMed PMID: 25043316.
Nouri-Neuville M, de Rocquancourt A, Cohen-Zarade S, Chapellier-Canaud M, Albiter M, Hamy AS, Giachetti S, Cuvier C, Espié M, de Kerviler É, de Bazelaire C. : Correlation between MRI and biopsies under second look ultrasound. Diagn Interv Imaging. 2014 Feb;95(2):197-211. doi: 10.1016/j.diii.2014.01.005. Epub 2014 Feb 10. PubMed PMID: 24525086.
Pierredon-Foulongne MA, Nougaret S, Bibeau F, et al. : Utility of reassessment after neoadjuvant therapy and difficulties in interpretation. Diagn Interv Imaging 2014; 95:495-503
Kraeber-Bodéré F, Bodet-Milin C, Rousseau C, Eugène T, Pallardy A, Frampas E, Carlier T, Ferrer L, Gaschet J, Davodeau F, Gestin JF, Faivre-Chauvet A, Barbet J, Chérel M. : Radioimmunoconjugates for the treatment of cancer. Semin Oncol. 2014 Oct;41(5):613-22. (IF 3.90).
Nougaret S, Reinhold C, Chong J, et al. : Incidental pancreatic cysts: natural history and diagnostic accuracy of a limited serial pancreatic cyst MRI protocol. Eur Radiol 2014; 24:1020-1029
Calais J, Lussato D, Menard J, de Kerviler E, Mongiat-Artus P, Castier Y, Merlet P. : Resection of a Solitary Pulmonary Metastasis from Prostatic Adenocarcinoma Misdiagnosed as a Bronchocele: Usefulness of 18F-Choline and 18F-FDG PET/CT. J Thorac Oncol. 2014 Dec;9:1826-9.
Varna M, Guilhem Bousquet G, Ferreira I, Goulard M, El-Bouchtaoui M, Mongiat Artus P, Verine J, de Kerviler E, Hernandez L, Leboeuf C, Escudier B, Legrès L, Setterblad N, Soliman H, Feugeas JP, Janin A, Bertheau P. : Evaluation of aggressive renal cell carcinomas preclinical models stability. Int J Clin Exp Pathol 2014 (sous presse).
Nougaret S, Guiu B. : Antiangiogenic therapy in metastatic renal cell carcinoma: more promises and more challenges for imaging. Diagn Interv Imaging 2014; 95:525-526
NM (cervical cancer) : 18F-FDG PET parameters during radio-chemotherapy to predict tumor recurrence in cervical cancer
D’Anastasi M, Schramm NA, Reiser MF, Graser A. : Criteria for radiological assessment of therapy response: Criteria-based appraisal. Radiologe. 2013 Apr;53(4):322-8. German
Francis Bouchet, Lilli Geworski, Bernd O. Knoop, Ludovic Ferrer, Alina Berriolo-Riedinger, Corinne Millardet, Marjolaine Fourcade, Antoine Martineau, Anne Belly-Poinsignon, Francis Djoumessi, Karine Tendero, Laurent Keros, Frederic Montoya, Christel Mesleard, Anne-Laure Martin, Franck Lacoeuille, Olivier Couturier. : Calibration Test of PET Scanners in a Multi-Centre Clinical Trial on Breast Cancer Therapy Monitoring Using 18F-FLT. PLoS ONE 8(3): e58152. doi:10.1371/journal.pone.0058152. Published: March 13, 2013
Nougaret S, Tirumani SH, Addley H, Pandey H, Sala E, Reinhold C. : Pearls and pitfalls in MRI of gynecologic malignancy with diffusion-weighted technique. AJR Am J Roentgenol 2013; 200:261-276
Nougaret S, Fujii S, Addley HC, et al. : Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience. J Magn Reson Imaging 2013; 38:726-732
Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G. : The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the “DISTANCE”? Radiology 2013; 268:330-344
NM (cervical cancer) : Investigating the contribution of pre- and per-treatment 18F-FDG PET-CT segmentation methodologies for post-treatment tumor recurrence prediction in cervical cancer
Khashper A, Addley HC, Abourokbah N, Nougaret S, Sala E, Reinhold C. : T2-hypointense adnexal lesions: an imaging algorithm. Radiographics 2012; 32:1047-1064
Kraeber-Bodéré F, Carlier T, Naegelen VM, Shochat E, Lumbroso J, Trampal C, Nagarajah J, Chua S, Hugonnet F, Stokkel M, Gleeson F, Tessier J. : Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trials. J Nucl Med. 2012 Dec;53(12):1836-46.
Battistella M, Robert C, Gossot D, Dupuy A, Avril MF, Mateus C, Basset-Seguin N, Ollivaud L, Kérob D, Baccard M, Lebbé C, Archimbaud A, de Kerviler E, Janin A, Viguier M. : Visceral lesions occurring during follow-up of melanoma patients: a true place for other diagnosis than melanoma metastasis. J Eur Acad Dermatol Venereol. 2012;26(5):602–610. doi:10.1111/j.1468-3083.2011.04129.x
Nougaret S, Addley HC, Colombo PE, et al. : Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics 2012; 32:1775-1800; discussion 1800-1773
Nougaret S, Rouanet P, Molinari N, et al. : MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology 2012; 263:409-418
de Bazelaire C, Rivet J, Varna M, Katsahian S, Leboeuf C, Sandid W, Bertheau P, Janin A. : Necrosis assessment in renal carcinoma. Hum Pathol. 2012 Jan;43(1):150-1; author reply 151-2. doi: 10.1016/j.humpath.2011.09.005. PubMed PMID: 22153030.
Ploussard G, Chambade D, Meria P, Gaudez F, Tariel E, Verine J, de Bazelaire C, Peraldi MN, Glotz D, Desgrandchamps F, Mongiat-Artus P. : Biopsy-confirmed de novo renal cell carcinoma (RCC) in renal grafts: a single-centre management experience in a 2396 recipient cohort. BJU Int. 2012 Jan;109(2):195-9. doi: 10.1111/j.1464-410X.2011.10315.x. Epub 2011 Aug 2. PubMed PMID: 21810160.
Chatal JF, Kraeber-Bodéré F, Goldenberg DM, Barbet J. Treatment of metastatic medullary thyroid cancer (MTC) with vandetanib: Need to stratify patients based on calcitonin doubling time before administering this therapy”. J Clin Oncol. 2012 Jun 10;30(17):2165 : Treatment of metastatic medullary thyroid cancer (MTC) with vandetanib: Need to stratify patients based on calcitonin doubling time before administering this therapy”. J Clin Oncol. 2012 Jun 10;30(17):2165
Salaun PY, Campion L, Bournaud C, Faivre-Chauvet A, Vuillez JP, Taieb D, Ansquer C, Rousseau C, Borson-Chazot F, Bardet S, Oudoux A, Cariou B, Mirallié E, Chang CH, Sharkey RM, Goldenberg DM, Chatal JF, Barbet J, Kraeber-Bodéré F. : Phase II trial of Anti-Carcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement, J Nucl Med. 2012 Aug;53(8):1185-92.
Botton E, Edeline J, Rolland Y, Vauléon E, Le Roux C, Mesbah H, Porée P, Audrain O, Raoul JL. : Cementoplasty for painful bone metastases: a series of 42 cases. Med Oncol. 2011 Apr 17.
O. Couturier, F. Paycha, A. Girma, C. Bodet-Milin, F. Baulieu, PY Salaün . : Guide pour la réalisation d’un examen de scintigraphie de vidange gastrique Médecine Nucléaire 2011, 35(12) : 676-685
de Bazelaire C, Sabatier F, Pluvinage A, de Kerviler É : CT-guided percutaneous biopsies. J Radiol. 2011 Sep;92(9):842-59. doi: 10.1016/j.jradio.2011.07.001. Epub 2011 Aug 24. French. PubMed PMID: 21944244.
Lacoeuille F, Hindré F, Venier-Julienne MC, Sergent M, Bouchet F, Jouaneton S, Denizot B, Askienazy S, Benoit JP, Couturier OF, Le Jeune JJ. : A starch-based microparticulate system dedicated to diagnostic and therapeutic nuclear medicine applications. Biomaterials. 2011 Nov;32(31):7999-8009. Epub 2011 Jul 23.
Vanpouille C., Lacoeuille F., Roux J., Aubé C., Garcion E., Lepareur N., Oberti F., Bouchet F., Noiret N., Garin E., Benoit JP, Couturier O., Hindré F. : Lipid nanocapsules loaded with rhenium-l88 reduce tumor progression in a rat hepatocellular carcinoma model. PloS One. 2011 Mar 7;6(3):e16926
Vanpouille-Box C, Lacoeuille F, Belloche C, Lepareur N, Lemaire L, LeJeune JJ, Benoît JP, Menei P, Couturier OF, Garcion E, Hindré F. : Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with (188)Re-lipid nanocapsules. Biomaterials. 2011 Oct;32(28):6781-90. Epub 2011 Jun 25.
O. Couturier, PY Salaün . : Comments regarding “consensus recommendations for gastric emptying scintigraphy”. Am J Gastroenterol. 2010 Dec;105(12):2705.
de Bazelaire C, Calmon R, Chapellier M, Pluvinage A, Frija J, de Kerviler E. : CT and MRI imaging in tumoral angiogenesis. Bull Cancer. 2010 Jan;97(1):79-90. doi: 10.1684/bdc.2010.0961. French. PubMed PMID: 19858045.
Zimmermann H. *, D’Anastasi M.*, Rjosk-Dendorfer D., Helck A., Meimarakis G., Reiser M., Clevert D.A. : Value of high-resolution contrast enhanced ultrasound in detection and characterisation of endoleaks after EVAR. Clin Hemorheol Microcirc. 2014 Jan 1;58(1):247-60.
Couturier O., Lacoeuille F., Lefebvre C., Hindré F., Vervueren L., Bouchet F., Le Jeune J.-J., Hustinx R. : Imagerie Phénotypique et peptides radiomarqués au gallium-68. Au delà des analogues de la somatostatine. Médecine Nucléaire, 2010, 34(5) : 299-306.
Querellou S, Keromnes N, Abgral R, Sassolas B, Le Roux PY, Cavarec MB, Le Duc-Pennec A, Couturier O, Salaun PY. : Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma. Nucl Med Commun. 2010 Sep;31(9):766-72
Verine J, Pluvinage A, Bousquet G, Lehmann-Che J, de Bazelaire C, Soufir N, Mongiat-Artus P. : Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol. 2010 Nov;58(5):701-10. doi: 10.1016/j.eururo.2010.08.031. Epub 2010 Aug 27. Review. PubMed PMID: 20817385.
Edeline J, Laguerre B, Rolland Y, Patard JJ. : Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma.. Ann Oncol. 2010 Jan;21(1):186-7
Cochet A, Berriolo-Riedinger A, Girault S, Rousseau C, Brunotte F, Couturier O. : Bone metastasis of a breast cancer detected by 3′-deoxy-3′-18F-fluorothymidine PET/CT. Nuklearmedizin. 2009;48(5):N45-6.
Read More

Other

Other : Une société consumériste d’information orientée vers une infosphère éthique / For an Ethical Infosphere in our Consumer-Oriented Information Society
Other : L’éthique face aux conflits d’intérêts de la recherche pharmaceutique
Other : Une médecine personnalisée tournée vers l’éthique.
Other : Télémédecine sous X ? Pourquoi prolonger cette protection individuelle historique ?
Endocrinology : Goericke-Pesch S, Wilhelm E, Ludwig C, Desmoulins PO, Driancourt MA, Hoffmann B. Evaluation of the clinical efficacy of Gonazon implants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog. Theriogenology. 2010 Apr 15;73(7):920-6.
Endocrinology : Ludwig C, Desmoulins PO, Driancourt MA, Goericke-Pesch S, Hoffmann B. Reversible downregulation of endocrine and germinative testicular function (hormonal castration) in the dog with the GnRH-agonist azagly-nafarelin as a removable implant “Gonazon”; a preclinical trial. Theriogenology. 2009 Apr 15;71(7):1037-45.
Immunology : Popa-Nita, Oana & Proulx, Sophie & Paré, Guillaume & Rollet-Labelle, Emmanuelle & H Naccache, Paul. (2009). Crystal-Induced Neutrophil Activation: XI. Implication and Novel Roles of Classical Protein Kinase C. Journal of immunology (Baltimore, Md. : 1950). 183. 2104-14. 10.4049/jimmunol.0900906.
Immunology : Popa-Nita, Oana & H Naccache, Paul. (2009). Crystal-induced neutrophil activation. Immunology and cell biology. 88. 32-40. 10.1038/icb.2009.98.
Other : SEREADMO : protocole de routage sécurisé pour réseaux ad hoc mobiles
PK/PD : Desmoulins PO, Burgaud S, Horspool LJ. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats. J Vet Pharmacol Ther. 2008 Aug;31(4):349-58.
Immunology : Popa-Nita, O & Paré, Guillaume & Gilbert, Caroline & H. Naccache, P. (2008). Monosodium urate crystal-induced activation of the tyrosine kinase Tec in human neutrophils. European Journal of Clinical Investigation. 38. 28-28.
Immunology : Popa-Nita, Oana & Marois, Louis & Paré, Guillaume & H Naccache, Paul. (2008). Crystal-induced neutrophil activation – X. Proinflammatory role of the tyrosine kinase Tec. Arthritis and rheumatism. 58. 1866-76. 10.1002/art.23801.
Immunology : Popa-Nita, Oana & Rollet-Labelle, Emmanuelle & Thibault, Nathalie & Gilbert, Caroline & Bourgoin, Sylvain & H Naccache, Paul. (2007). Crystal-induced neutrophil activation. IX. Syk-dependent activation of class Ia phosphatidylinositol 3-kinase. Journal of leukocyte biology. 82. 763-73. 10.1189/jlb.0307174.
Endocrinology : Rubion S, Desmoulins PO, Rivière-Godet E, Kinziger M, Salavert F, Rutten F, Flochlay-Sigognault A, Driancourt MA. Treatment with a subcutaneous GnRH agonist containing controlled release device reversibly prevents puberty in bitches. Theriogenology. 2006 Oct;66(6-7):1651-4.
Immunology : Desaulniers, Philippe & Marois, Sebastien & Paré, Guillaume & Popa-Nita, Oana & Gilbert, Caroline & H Naccache, Paul. (2006). Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals. The Journal of rheumatology. 33. 928-38.
Immunology : Etchart N, Desmoulins PO, Chemin K, Maliszewski C, Dubois B, Wild F, Kaiserlian D. Dendritic cells recruitment and in vivo priming of CD8+ CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein. J Immunol. 2001 Jul 1;167(1):384-91.
Immunology : Tomasello E, Desmoulins PO, Chemin K, Guia S, Cremer H, Ortaldo J, Love P, Kaiserlian D, Vivier E. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity. 2000 Sep;13(3):355-64.
MM Hell, X Ding, M Rubeaux, P Slomka, H Gransar, D Terzopoulos, … : Epicardial adipose tissue volume but not density is an independent predictor for myocardial ischemia. Journal of cardiovascular computed tomography 10 (2), 141-149
I Išgum, BD de Vos, JM Wolterink, D Dey, DS Berman, M Rubeaux, … : Automatic determination of cardiovascular risk by CT attenuation correction maps in Rb-82 PET/CT. Journal of Nuclear Cardiology 25 (6), 2133-2142
S Krishnan, Y Otaki, M Doris, L Slipczuk, Y Arnson, M Rubeaux, D Dey, … : Molecular imaging of vulnerable coronary plaque: A pathophysiologic perspective. Journal of Nuclear Medicine 58 (3), 359-364
PJ Slomka, M Rubeaux, G Germano : Quantification with normal limits: New cameras and low-dose imaging. Journal of Nuclear Cardiology 24 (5), 1637-1640
MC Hyun, J Gerlach, M Rubeaux, PJ Slomka : Technical consideration for dual ECG/respiratory-gated cardiac PET imaging. Journal of Nuclear Cardiology 24 (4), 1246-1252
M Rubeaux, J Mahalingam, F Gomez, M Nelson, A VANHAUDENHUYSE, … : Thalamic volume as a biomarker for Disorders Of Consciousness. Progress in Biomedical Optics and Imaging. Proceedings of SPIE
de Margerie-Mellon C, Belin L, Boussouar S, et al. : Computed tomography assessment of peripheral traction bronchiolectasis: impact of minimal intensity projection. Eur Respir J. 2020;55(1):1901388. Published 2020 Jan 23. doi:10.1183/13993003.01388-2019
Xhaard A, Porcher R, Bergeron A, Alanio A, Touratier S, Bretagne S, de Margerie-Mellon C, Sicre de Fontbrune F, Itzykson R, Coman T, Robin M, Cabannes-Hamy A, Socié G, Peffault de Latour R. : Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study. Ann Hematol. 2019 Apr; 98(4):1033-1035.
Rech JS, Arnulf B, de Margerie-Mellon C, et al. : Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series. Am J Hematol. 2019;94(11):1214–1226. doi:10.1002/ajh.25608
Le Guen P, Chevret S, Bugnet E, et al. : Management and outcomes of pneumothorax in adult patients with Langerhans cell Histiocytosis. Orphanet J Rare Dis. 2019;14(1):229. Published 2019 Oct 21. doi:10.1186/s13023-019-1203-5
Tazi A, Lorillon G, Haroche J, Neel A, Dominique S, Aouba A, Bouaziz JD, de Margerie-Mellon C, Bugnet E, Cottin V, Comont T, Lavigne C, Kahn JE, Donadieu J, Chevret S. : Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study. Orphanet J Rare Dis. 2017 May 22;12(1):95.
de Kerviler E, Maravilla K, Meder JF, Naggara O, Dubourdieu C, Jullien V, Desché P. : Adverse Reactions to Gadoterate Meglumine: Review of Over 25 Years of Clinical Use and More Than 50 Million Doses. Invest Radiol. 2016;51:544-51.
Nougaret S, Ragucci M, Bach AM, Carollo G, Mannelli L. : Incidental Detection of Femoral Pseudoaneurysm at 18F-FDG PET/CT. Clin Nucl Med 2016; 41:e68-69
de Margerie-Mellon C, Dion G, Darlay J, Ridene I, Kambouchner M, Brauner N et al. : High-resolution computed tomography to differentiate chronic diffuse infiltrative lung diseases with chronic multifocal consolidation patterns using logical analysis of data. Sarcoidosis Vasc Diffuse Lung Dis. dec 2016; 23;33(4):355-371
Tazi A, de Margerie-Mellon C, Vercellino L, Naccache JM, Fry S, Dominique S et al. : Extrathoracic investigation in adult patients with isolated pulmonary langerhans cell histiocytosis. Orphanet J Rare Dis. 2 feb 2016;11:11.
Dercle L, Chisin R, Ammari S, Gillebert Q, Ouali M, Jaudet C, Delord JP, Dierickx L, Zerdoud S, Schlumberger M, Courbon F : Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome? . Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):397-408. doi: 10.1007/s00259-014-2938-9.
Tazi A, de Margerie C, Naccache JM, Fry S, Dominique S, Jouneau S, et al. : The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study. Orphanet J Rare Dis. mar 2015;10:30.
Mezidi M, Belafia F, Nougaret S, et al. : Interferon gamma in association with immunosuppressive drugs withdrawal and antifungal combination as a rescue therapy for cerebral invasive Aspergillosis in a liver transplant recipient. Minerva Anestesiol 2014; 80:1359-1360
Jung B, Nougaret S, Conseil M, et al. : Sepsis is associated with a preferential diaphragmatic atrophy: a critically ill patient study using tridimensional computed tomography. Anesthesiology 2014; 120:1182-1191
Ernst O, Thuret L, Petit P, Ameur F, Loundou AD, de Kerviler E, Izzillo R, Leroy-Willg A, Pascal L, Verlhac S, Mordon S, Feneaux P, Rose C. : Iron overload of hematological origin: Validation of a screening procedure for cardiac overload by MRI in routine clinical practice. Diagn Interv Imaging 2013 (sous presse).
Dierickx O. Lawrence, Huyghe E, Nogueira D, Zerdoud S, Bujan J, Séverine Brillouet, O Caselles, Plante P, Courbon F, Zerdoud S, Brillouet S, Caselles O, Courbon F. : Functional testicular imaging using PET/CT with 18F-Fluoro-deoxyglucose’ : Eur J Nucl Med Mol Imaging (2012) 39:129–137
Tazi A, Marc K, Dominique S, de Bazelaire C, Crestani B, Chinet T, Israel-Biet D, Cadranel J, Frija J, Lorillon G, Valeyre D, Chevret S. : Serial computed tomography and lung function testing in pulmonary Langerhans’ cell histiocytosis. Eur Respir J. 2012 Oct;40(4):905-12. Epub 2012 Mar 22. PubMed PMID: 22441752.
Signe J, Jung B, Nougaret S, et al. : Pneumonia in immunocompromised patients: more than meets the eye. Am J Respir Crit Care Med 2012; 186:e18
Jung B, Clavieras N, Nougaret S, et al. : Effects of etomidate on complications related to intubation and on mortality in septic shock patients treated with hydrocortisone: a propensity score analysis. Crit Care 2012; 16:R224
Verhoest G, Rohou T, Gerard F, Huet R, Bensalah K. : An explosive urinary tract infection. Lancet. 2012 Oct 20;380(9851):1418. No abstract available.
C. Agius, H. Rakotonirina, F. Lacoeuille, F. Bouchet, L. Vervueren, J.-J. Le Jeune, O. Couturier. : Infection de prothèse vasculaire : 18TEP-FDG vs scintigraphie aux leucocytes marqués (planaires et TEMP/TDM). Médecine Nucléaire 2011, 35(12) : 628-640
Nougaret S, Baron MP, Thouvenin Y, Hoa D, Cyteval C. : Imaging of the postoperative knee: normal and pathologic findings. J Radiol 2011; 92:8-19
Prunel P, Verhoest G, Besnard S, Rohou T, Rioux-Leclercq N, Bensalah K. : Erdheim-Chester disease: report of a case and literature review. Prog Urol. 2012 May;22(5):310-2. Epub 2011 Dec 22. Review. French.
D’Anastasi M, Birkenmaier C, Schmidt GP, Wegener B, Reiser MF, Baur-Melnyk A. : Correlation between vacuum phenomenon on CT and fluid on MRI in degenerative disks.AJR Am J Roentgenol. 2011 Nov;197(5):1182-9.
Jung B, Nougaret S, Chanques G, et al. : The absence of adrenal gland enlargement during septic shock predicts mortality: a computed tomography study of 239 patients. Anesthesiology 2011; 115:334-343
Fregeville A, de Bazelaire C, Zagdanski A, Albiter M, Desgrandchamps F, De Kerviler E. : [Value of whole body CTA in the management of brain-dead patients]. J Radiol. 2010 Jan;91(1 Pt 1):37-44. French. PubMed PMID: 20212375.
Nougaret S, Jung B, Aufort S, Chanques G, Jaber S, Gallix B. : Adrenal gland volume measurement in septic shock and control patients: a pilot study. Eur Radiol 2010; 20:2348-2357
Prunel P, Verhoest G, Boudry G, Rohou T, Bouget J, Patard JJ, Guillé F, Bensalah K. : Impact of low-dose CT in the diagnosis and treatment of renal colic in emergency department. Prog Urol. 2010 Oct;20(9):633-7. Epub 2010 Jun 9. French.
Nougaret S, Aufort S, Ramos J, et al. : Hepatic peliosis: an entity to remember. J Radiol 2009; 90:1745-1749
Read More

Information

Europe

  • 13 Impasse Serge Reggiani
    44815 Saint-Herblain
    FRANCE
  • Phone: +33 2 53 59 12 90

North America

  • 55 Fifth Avenue Suite 1807
    New York, NY 10003
    USA
  • Phone: +1 646 797 2724

Get Updates

Sign up for the Newsletter

[mc4wp_form id="128"]